NEWS: Help R.E.A.C.T. give them a voice.

SPELLERS the movie won Best Documentary and Donor’s Choice Award at its premier at the Phoenix Film Festival and this film is changing the way the world perceives non-speaking individuals with autism. The SPELLERS film is finally leading practitioners, educators, and even families to re-evaluate expectations and therapeutic approaches to this complex, multifaceted disorder.

The documentary SPELLERS pushes us to dig deeper, reflect on our own biases and develop new and appropriate therapeutic approaches that best serve non-speaking individuals with autism and apraxia. It shows us that “assuming competence” leads to better outcomes and breakthroughs. Watch the trailer

REACT is encouraging the public, including providers and educators, to watch the film SPELLERS to be inspired to make a difference in the lives of individuals who do not have access to these communication interventions. 

REACT continues to work diligently to get this film in front of providers and educators. In 2023, REACT offered a 2.5 AMA PRA Category 1 Credits™ Continuing Medical Education course titled Multidisciplinary Perspectives of the Film SPELLERS: Considerations of Implicit Bias & Therapeutic Interventions For Non-Speaking Individuals with Autism. We encourage providers and educators to watch this discussion and for employers to host this film and course as an in-service opportunity for their staff.

REACT is also committed to providing scholarships to non-speaking individuals and their families to get SPELLERS ACC training. Since this training is not provided by school districts, insurance plans, or government assistance programs, many who desperately want this training are deprived of access due to financial limitations. Your donations are vital to helping this scholarship program to be successful.

Autism On The Rise

For the last three decades we have seen a drastic increase in neurodevelopmental disorders and chronic disease in children. According to the Centers for Disease Control and Prevention autism has risen from 1 in every 10,000 to 1 in 36 children. Boys are 4 times more likely to have autism with a ratio of 4.2  to 1. The CDC also finds that approximately seventeen percent (17%) of American children now have a developmental disability. That’s 1 in 6 American children have a diagnosis of autism, ADHD, cerebral palsy, or other developmental disability.

Autoimmune Disease

Autoimmune disease has also skyrocketed, especially in our children.  Research by scientists at the National Institutes of Health report that over the course of 25 years, autoimmune diseases have risen by 50% and that adolescents are acquiring autoimmune problems at twice the rate of adults.

What is happening to our children?

We have many clues that environmental toxins could be the culprit. From heavy metals, to plastics, to chemicals and pesticides, to wireless radiation, to pharmaceuticals—our children are being exposed to more toxins than ever.

It’s time to find answers and stop the epidemic of chronic disease in our children. We desperately need more research to understand the root causes of this drastic rise in neurodevelopmental disorders and chronic disease in our children. REACT, Inc. believes every child should have access to effective treatment(s), yet many families cannot find nor afford treatments that give their child the best chance at successful outcomes.

There is hope for a better future!

We need your help. We need answers! It’s time to discover what is causing our youth to be so sick. The keys to healing our children and unlocking the mysteries of the root causes are not out of reach. Together, we can support the research and support families. There is hope for a better tomorrow!


Please consider a one-time or monthly donation and help bring hope for a healthier tomorrow.

Our Mission:

The mission of Research and Education for Autistic Children’s Treatment Inc (REACT, Inc), a non-profit 501(c)(3), is to increase autism awareness, fund individual and family treatments, provide education, fund and support research, and help develop treatment protocols for autism and other neurological disorders, developmental disorders, and chronic illnesses.